UTS BRIDGINGTHE GAP

SEMINAR SERIES

Join us for an interactive session that will focus on new technologies in Multiple Myelomadisease detection and management.

A light lunch will be provided at 1.00pm with the opportunity to network.

NOVEMBER 11, 2019 • 12.00PM - 1.30PMUTS | CB07.02.025

PROFESSOR DOUGLAS JOSHUA

PROFESSOR MARY BEBAWY

For more information, contact the TCRN on 02 9385 1395

Professor Emeritus Douglas Edgar Joshua is an Emeritus Professor in Medicine atUniversity of Sydney, and Consultant Hematologist at the Institute of Hematology,Royal Prince Alfred Hospital. He received his BSC, MB BS, and his D Phil degreesfrom University of Sydney and University of Oxford. He is a fellow of The RoyalAustralasian College of Physicians and the Royal College of Pathologists ofAustralasia. Prof. Joshua has a long standing interest in both

Professor Mary Bebawy has a PhD in Pharmacy (USYD) and Head of theLaboratory of Cancer Cell Biology and Therapeutics, Graduate School of HealthUTS. She has an active research portfolio focusing on the molecular basis of cancerrelapse. She is an internationally recognized cancer researcher and pharmaceuticalscientist with a background in commercial R & D. Her team were the first todiscover the role of extracellular vesicles (EVs) in the spread of cancer multidrug resistance (MDR) (Bebawy et al., 2009).

basic and clinical research in Myeloma and has beensupported by the National Health and Medical ResearchCouncil, Multiple Myeloma Research Foundation, InternationalMyeloma Foundation, NSW State Cancer Council, Cancerinstitute of NSW , the University of Sydney Cancer esearchFund and the Sydney Foundation for Medical research.